Senior Pharmacovigilance Specialist (Remote)

OrciMed Life Sciences Philippines OPC; Metro Manila; Remote; PHP 900,000 - 1,300,000; Full time

Job summary

OrciMed Life Sciences Philippines OPC is seeking a highly detail-oriented Senior Drug Safety Specialist to join the Pharmacovigilance team. The successful candidate will manage intake, processing, evaluation, and reporting of safety cases arising from clinical trials while ensuring compliance with global pharmacovigilance regulations and internal procedures.

This role requires hands-on experience in clinical trial case processing, expedited safety reporting, and regulatory submissions.

Qualifications

• Bachelor’s degree in Pharmacy, Nursing, Life Sciences, or related healthcare field.

Responsibilities

• Handle intake, processing, evaluation, and reporting of safety cases from clinical trials.
• Prepare, review, and submit safety reports to regulatory authorities and ethics committees, including expedited and periodic submissions.
• Ensure compliance with global pharmacovigilance regulations, study protocols and internal procedures.
• Maintain ability to meet strict regulatory timelines and communicate effectively in writing and verbally.

Skills

AE reporting

SAE reporting

SUSAR reporting

Regulatory timelines

Attention to detail

Written communication

Verbal communication

Clinical trial pharmacovigilance

Pharmacovigilance experience

Education

Bachelor's degree in Pharmacy, Nursing, Life Sciences

Tools

Argus Safety

ARISg

PV Edge

Veeva Vault Safety

EDC Databases

Job description

OrciMed Life Sciences Philippines OPC is seeking a highly detail-oriented Senior Drug Safety Specialist to join the Pharmacovigilance team. The successful candidate will manage intake, processing, evaluation, and reporting of safety cases arising from clinical trials while ensuring compliance with global pharmacovigilance regulations and internal procedures.

This role requires hands-on experience in clinical trial case processing, expedited safety reporting, and regulatory submissions.